S 3220 · 118th Congress
A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.
This bill expands an existing government program designed to encourage pharmaceutical companies to develop treatments and prevention methods for rare tropical diseases. Specifically, it adds coccidioidomycosis—commonly called "Valley Fever"—to the list of diseases covered by this incentive program. Here's how it wo…
- Sponsor
- Kelly, Mark (D-AZ)
- Introduced
- 2023-11-02
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Digging through Congress... 🔍